In Brief | Infectious Diseases, Vaccines & Antimicrobials | Paedeatrics & Neonatology
 
The impact of early antibiotic exposure on childhood atopic dermatitis, asthma, and inhaled corticosteroid use


Time to read: 02:38
Time to listen: 06:24

 
Published on MedED:  20  November 2024
Originally Published: 28 September 2024
Sourced: European Journal of Paediatrics 
Type of article: In Brief
MedED Catalogue Reference:
 MPIB0015
Category: Infectious Diseases, Vaccines & Antimicrobials
Cross Reference: Paediatrics & Neonatology, Respiratory Diseases, Dermatology

Keywords: atopic dermatitis, asthma, cortico-steroid use, paeditrics neonates

 

Key Takeaway
Early antibiotic exposure, both in the neonatal period and before six months, is associated with an increased risk of atopic dermatitis, asthma, and the need for inhaled corticosteroids later in childhood. However, neonatal antibiotic exposure due to confirmed infection does not seem to be linked to asthma or corticosteroid use.
 
Top

Originally published in The European Journal of Paediatrics 28 September 2024 This summary does not represent the original research, nor is it intended to replace the original research. Access the full Disclaimer Information
 

 
Early antibiotic exposure in neonates and infants, while critical for treating infections, may have unintended consequences. 
 
This study, published in the European Journal of Paediatrics, sought to determine whether early antibiotic exposure increases the risk of childhood atopic dermatitis, asthma, or inhaled corticosteroid use.

The study reviewed the data from 11,255 children born in Southwest Finland between 2008 and 2010.
 
Children were grouped by neonatal antibiotic exposure as either a) no exposure, b) empirical antibiotic therapy (discontinued after infection was ruled out), or c) antibiotics for confirmed or clinically diagnosed infection.
 
Outcomes assessed included physician-diagnosed atopic dermatitis, asthma, or inhaled corticosteroid use by age 8-9 years.
 
Confounding factors such as older siblings, maternal BMI, smoking, pregnancy duration, delivery type, child's sex, and intrapartum antibiotics were controlled for.
 
1,255 children (11.2%) were exposed to antibiotics in the first 14 days of life:
  • 592 (5.3%) received empirical antibiotics (median duration: 2 days)
  • 663 (5.9%) received antibiotics for confirmed or clinically diagnosed infection (median duration: 7 days)
  • 1,777 children (15.8%) received antibiotics after the neonatal period but before 6 months
 
 
The following findings were recorded:
 
Atopic Dermatitis
852 infants (7.6%) were diagnosed with atopic dermatitis during follow-up.

After adjusting for confounding factors, neonatal antibiotic exposure due to confirmed infection was associated with an increased risk of atopic dermatitis (OR 1.49).

Empirical antibiotic treatment showed no significant association.

Early antibiotic exposure before six months was also linked to a higher risk of atopic dermatitis (OR 1.38).
 
Asthma
849 infants (7.5%) were diagnosed with asthma.

No difference in neonatal antibiotic exposure was found between children who developed asthma and those who did not.

However, antibiotic exposure after the neonatal period but before six months was associated with a higher cumulative incidence of childhood asthma (OR 1.56).
 
 
Inhaled Corticosteroid Use
1,876 infants (16.7%) were prescribed inhaled corticosteroids.

Neonatal antibiotic exposure was not associated with inhaled corticosteroid use.

Antibiotic exposure before six months was more common in children who later required inhaled corticosteroids, with a significant association (OR 1.88).
 
CRP and Inflammatory Response
Plasma CRP concentrations were measured in 1,331 (11.8%) study subjects during the first week of life.

CRP levels were higher in neonates with confirmed infections compared to those not exposed to antibiotics or with empirical antibiotics ruled out.

However, maximum CRP concentrations were not associated with an increased risk of atopic dermatitis, asthma, or inhaled corticosteroid use later in childhood.
 
Composite Outcome: Asthma and Inhaled Corticosteroid Use
769 children (6.8%) were diagnosed with asthma and prescribed inhaled corticosteroids.

Exposure to antibiotics both in the neonatal period and before six months was more common in children who developed asthma and required inhaled corticosteroid therapy.
 
 
These findings indicate that neonatal antibiotic exposure for clinically diagnosed or confirmed infection is associated with increased occurrence of atopic dermatitis and antibiotic use after the neonatal period. 

Additionally, use during the first six months of life is associated with an increased risk of atopic dermatitis, asthma, and inhaled corticosteroid use later in childhood. Further research is required to determine the causal mechanisms underlying the associations. 

 
Access the original research article. Back to top

Disclaimer
This article is reproduced under the terms of CC-BY-Licence. It is in no way presented as an original work.  Every effort has been made to attribute quotes and content correctly. Where possible, all information has been independently verified. The Medical Education Network bears no responsibility for any inaccuracies which may occur from the use of third-party sources. If you have any queries regarding this article contact us 

Fact-checking Policy
The Medical Education Network makes every effort to review and fact-check the articles used as source material in our summaries and original material. We have strict guidelines in relation to the publications we use as our source data, favouring peer-reviewed research wherever possible. Every effort is made to ensure that the information contained here is an accurate reflection of the original material. Should you find inaccuracies, out of date content or have any additional issues with our articles, please
 contact us 

 
Rapid SSL

The Medical Education Network
Powered by eLecture, a VisualLive Solution